BCG-Refractory Bladder Cancer: New Therapies & Treatment Choices скачать в хорошем качестве

BCG-Refractory Bladder Cancer: New Therapies & Treatment Choices

BCG-refractory disease presents some of the toughest management challenges in bladder cancer. Dr. Amy Luckenbaugh reviews the evidence and regimens for newly approved Adstiladrin and Anktiva. She also emphasizes that for certain patients, such as those with high tumor burden or significant symptoms, early cystectomy may offer the best outcomes and quality of life. Watch the full episode here:    • Видео   This campaign is supported by an educational grant from UroGen Pharma. UGN-102 was approved by the FDA on June 12, 2025. #URO253 #bladdercancer #BCG #intravesicaltherapy #oncology #cystectomy --- The BackTable Urology Podcast is a resource for practicing urologists to learn tips, techniques, and practical advice from their peers in the field. Listen on BackTable.com/Urology or on the streaming platform of your choice. Get notified when new episodes drop! Subscribe to the BackTable Urology Podcast on your go-to podcast platform, and follow us on your social media platform of choice for regular updates. ► https://www.backtable.com/shows/urology